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OBJECTIVE—Temperature and nutrient homeostasis are two
interdependent components of energy balance regulated by
distinct sets of hypothalamic neurons. The objective is to exam-
ine the role of the metabolic signal insulin in the control of core
body temperature (CBT).
RESEARCH DESIGN AND METHODS—The effect of preoptic
area administration of insulin on CBT in mice was measured by
radiotelemetry and respiratory exchange ratio. In vivo
2-[
18F]ﬂuoro-2-deoxyglucose uptake into brown adipose tissue
(BAT) was measured in rats after insulin treatment by positron
emission tomography combined with X-ray computed tomogra-
phy imaging. Insulin receptor–positive neurons were identiﬁed
by retrograde tracing from the raphe pallidus. Insulin was locally
applied on hypothalamic slices to determine the direct effects of
insulin on intrinsically warm-sensitive neurons by inducing hy-
perpolarization and reducing ﬁring rates.
RESULTS—Injection of insulin into the preoptic area of the
hypothalamus induced a speciﬁc and dose-dependent elevation
of CBT mediated by stimulation of BAT thermogenesis as shown
by imaging and respiratory ratio measurements. Retrograde
tracing indicates that insulin receptor–expressing warm-sensi-
tive neurons activate BAT through projection via the raphe
pallidus. Insulin applied on hypothalamic slices acted directly on
intrinsically warm-sensitive neurons by inducing hyperpolariza-
tion and reducing ﬁring rates. The hyperthermic effects of insulin
were blocked by pretreatment with antibodies to insulin or with
a phosphatidylinositol 3–kinase inhibitor.
CONCLUSIONS—Our ﬁndings demonstrate that insulin can
directly modulate hypothalamic neurons that regulate thermo-
genesis and CBT and indicate that insulin plays an important role
in coupling metabolism and thermoregulation at the level of
anterior hypothalamus. Diabetes 59:43–50, 2010
C
ore body temperature (CBT) and nutrient ho-
meostasis are important components of energy
balance that can affect each other by mecha-
nisms that are not clearly understood. In ho-
meotherms, both are regulated centrally by distinct
hypothalamic nuclei and neurons. The preoptic area
(POA) is essential for the regulation of CBT (1). This
region contains temperature- (warm and cold) sensitive
neurons that are considered pivotal in sensing and re-
sponding to local- and skin-temperature changes (2,3).
Nutrient homeostasis is regulated by different hypotha-
lamic regions, the paraventricular and the arcuate nucleus,
that contain neurons responding to changes in the level of
glucose, lipids, ghrelin, leptin, and insulin, respectively
(4,5). Intracerebroventricular injection of insulin reduced
the unit activity of POA neurons sensitive to peripheral
changes in scrotum temperature, indicating that this hor-
mone may modulate thermoregulatory responses (6). Be-
cause the insulin receptor was detected in the POA
(5,7–9), we hypothesized that insulin could elevate CBT by
directly acting on temperature-sensitive neurons in the
POA. Furthermore, our data (unpublished results) on
single-neuron chipping of temperature-/warm-sensitive
neurons in the POA showed the presence of insulin
receptor mRNA in these neurons whose ﬁring activity is
inversely correlated with the activation of thermogenesis
in brown adipose tissue (BAT) (10).
RESEARCH DESIGN AND METHODS
All procedures were approved by the Institutional Animal Care and Use
Committee of the Scripps Research Institute and were carried out on 3- to
4-month-old male C57BL/6J mice. Animals were maintained on regular chow
(Harlan Teklad LM-485 Diet 7012; carbohydrate 65% kcal, fat 13%, metaboliz-
able energy 3.41 kcal/g). Access to food and water was ad libitum, and the
light:dark cycle was 12:12 h with lights on at 7:00 A.M.
For telemetry studies, male mice were anesthetized with isoﬂorane (induc-
tion 3–5%, maintenance 1–1.5%) and surgically implanted with radio telemetry
devices (TA-F20; Data Sciences) into the peritoneal cavity for CBT and
locomotor activity measurement. Mice were allowed to recover for 2 weeks
and then were submitted for freely moving telemetry recording (each group
n  4–6) for 7 days. Mice were individually housed in a Plexiglas cage in a
room maintained at 25  0.5°C on a 12:12 h light:dark cycle (lights on at 6:00
A.M.) with ad libitum access to food and water. The cages were positioned onto
the receiver plates (RPC-1; Data Sciences), and radio signals from the
implanted transmitter were continuously monitored and recorded. CBT and
locomotor activity (number of horizontal movements) were continuously
monitored with a fully automated data acquisition system (Dataquest ART;
Data Sciences). Recordings were made for 72 h before treatment to
ascertain that baseline levels of temperature were stable and that no ongoing
febrile response confounds the results.
Insulin (I1507; Sigma, St. Louis, MO) was predissolved in saline and
subsequently diluted in artiﬁcial cerebrospinal ﬂuid (aCSF). Phosphatidylino-
sitol 3–kinase inhibitor (PI3K-I), LY294002 (70920; Cayman Chemical, Ann
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concentration 5% DMSO). Injections of insulin (or vehicle aCSF), PI3K-I (or
vehicle aCSF with 5% DMSO), or insulin antibodies (I8510; Sigma, St. Louis,
MO) (or vehicle aCSF) were administered directly to the POA through the
POA-implanted cannula (anterior-posterior [AP] from bregma  0.38 mm,
lateral [Lat]  midline, ventral [V]  3.8 mm, cannula 26 GA, 10 mm length)
using an injector (33 GA, protruding 0.4 mm beyond the tip of the cannula,
total length 10.4 mm) connected to plastic tubing and a microsyringe (10 l)
in a volume of 0.5 l over a period of 5 min to allow diffusion (n  5 mice per
group).
Indirect calorimetry was performed simultaneously in acclimated, singly
housed, standard diet–fed mice using a computer-controlled open-circuit
system (Oxymax System) that is part of an integrated Comprehensive Lab
Animal Monitoring System (CLAMS; Columbus Instruments, Columbus, OH).
Animals are tested in clear respiratory chambers (20  10  12.5 cm) with
a stainless steel elevated wire ﬂoor. Each of these chambers is equipped with
a food tray connected to a balance. Room air is passed through chambers at a
ﬂow rate of 0.5 l/min. Exhaust air from each chamber is sampled at 30-min
intervals for 1 min. Sample air is sequentially passed through O2 and CO2
sensors (Columbus Instruments) for determination of O2 and CO2 content,
from which measures of oxygen consumption (VO2) and carbon dioxide
production (VCO2) are estimated. Outdoor air reference values are sampled
after every four measurements. Gas sensors are calibrated prior to the onset
of experiments with primary gas standards containing known concentrations
of O2,C O 2, and N2 (Airgas Puritan Medical, Ontario, Canada). Respiratory
exchange ratio (RER) is calculated as the ratio of VCO2 to VO2. Energy
expenditure measures (VO2, VCO2, and heat formation [{3.815  1.232  RER}
 VO2 {in liters}]) are corrected for estimated effective metabolic mass per
Kleiber power function. Mice undergoing indirect calorimetry are acclimated
to the respiratory chambers for 3–4 days before the onset of study. Data are
recorded under ambient room temperature clamped at 25°C, beginning from
the onset of the light cycle, 24 h/day for 3 days.
Positron emission tomography and computed tomography imaging.
Positron emission tomography (PET)/computed tomography (CT) imaging in
this study was carried out with 2-[
18F]ﬂuoro-2-deoxyglucose (
18F-FDG) on
12-week-old male Sprague Dawley rats (mean body wt 250 g). Rats are known
to have a relatively large amount of BAT in the interscapular region and thus
are often used in research for BAT activation (11). Each rat received 18.5 MBq
of
18F-FDG via intraperitoneal injection, and 30 min later they were anesthe-
tized with isoﬂorane (5% induction, 1–2% maintenance) and imaged with a
combined PET/CT scanner (Siemens Medical Solutions) designed for small
rodents at baseline and after microinjection of insulin into the preoptic area
(AP  0.9, lat  midline, V  8.0 mmm from dura) at 15, 30, 60, and 180 min.
In brief, CT for attenuation correction and 5-min emission PET were per-
formed, followed by thin-slice (1.5 mm thick) CT. PET and thin-slice CT
images were reconstructed as 35-cm ﬁeld-of-view images, and the PET and CT
image sections at the same location were manually fused using image analysis
software (Photoshop 6.0; Adobe Systems). The mild
18F-FDG uptake in skin
and the contours of normal organs were used as landmarks. The PET and CT
images were also intrinsically registered because of their acquisition on the
dedicated PET/CT scanner.
18F-FDG uptake in interscapular BAT was evalu-
ated using the PET, CT, and fused PET/CT images. Animal’s body temperature
was maintained at 37°C by a heat lamp (Temperature Controller RET-3
Temperature probe and HL-1 Heat Lamp; Physitemp Instruments, Clifton, NJ)
in between periods of recording to avoid hypothermia during isoﬂorane
anesthesia.
PET data were analyzed by visual interpretation of coronal, sagittal, and
transverse slices alone and in cross-referenced situations. When
18F-FDG PET
uptake increase was observed, two levels were identiﬁed in comparison with
normal activity: moderate (more or less twice the activity in a reference
region) or intense (markedly higher than the reference activity). PET and
conventional imaging were interpreted separately, and the results were then
compared with each other and, in certain cases, with the physiological
information on hyperthermia. Bone scans and CT images were read indepen-
dently by two nuclear medicine physicians and by two radiologists,
respectively.
Slice preparation. The brain was quickly removed from C57BL/6 mice at
22–35 days old and submerged in ice-cold oxygenated (95% O2/5% CO2) normal
aCSF; composition was (in mmol/l) NaCl 126, KCl 3.5, CaCl2 2, MgSO4 1,
NaH2PO4 1.25, NaHCO3 26, and glucose 10 (pH 7.4). Coronal slices (350 m
thick) containing the POA were cut by a microslicer (Vibratome).
Patch clamp recording. Standard tight-seal recordings were performed in
current clamp mode (I-fast) with an Axopatch 200B ampliﬁer to record
spontaneous action potentials. The external recording solution was aCSF. In
some recordings 9 mmol/l glucose was replaced by 9 mmol/l mannitol. The
pipette solution used was (in mmol/l) 130 K-gluconate, 10 KCl, 10 HEPES, 2
MgCl2, 0.5 EGTA, 2 ATP, and 1 GTP (pH 7.4). Glass micropipettes were pulled
with a horizontal puller (P-87; Sutter Instruments, Novato, CA) using borosili-
cate glass. The electrode resistance after backﬁlling was 2–4 M. All voltage
measurements were corrected for the liquid junction potential (9 mV).
Temperature control. The temperature of the external solution was con-
trolled with an HCC-100A heating/cooling bath temperature controller (Dagan
Corporation), a fast temperature controller equipped with a Peltier element.
To prevent changes induced in the electrode reference potential, the ground
electrode was thermally isolated in a separate bath connected to the recording
bath by a ﬁlter paper bridge.
Data acquisition and analysis. Recordings were digitized using a Digidata
1320A interface and analyzed using Pclamp9 (Axon Instruments, Union City,
CA) software package and stored on the disk of a computer. After establishing
whole-cell conﬁguration (or perforated whole cell), the spontaneous activity
of the neuron was recorded for 2–4 min to determine its control behavior (at
36–37°C), after which it was tested for temperature sensitivity with a
temperature cycle of at least 33–39°C. The ﬁring rate was determined for each
10-s interval and plotted against the temperature using Sigmaplot software.
The criteria for classifying a neuron as being warm sensitive were the same as
those used by previous investigations of temperature-sensitive neurons (1).
Brieﬂy, the thermal coefﬁcient is deﬁned as the slope of the linear regression
of the ﬁring rate plotted as a function of temperature. This plot was
determined over a temperature range of 3°C in which a neuron was most
sensitive. A warm-sensitive neuron is deﬁned as having a thermal coefﬁcient
0.8 impulses  s
1  C
1. Neurons displaying nonreversible ﬁring rate changes
during changes in temperature were excluded.
Immunoblotting. Mice were anesthetized and POA tissues were obtained
and homogenized in freshly prepared ice-cold radioimmunoprecipitation
assay buffer (Thermo Scientiﬁc, IL) including 1 mmol/l Na3VO4, 1 mmol/l NaF,
EDTA-free protease inhibitor, and PhosSTOP (Roche, Indianapolis, IN) 90 min
after the injection of vehicle (aCSF) or insulin (0.03 IU) (Sigma) into the POA.
Insoluble material was removed by centrifugation (15,000 g, 2 min) at 4°C.
Sample buffer (0.125 mol/l Tris pH 6.8, 0.04% glycerol, 0.4% SDS, 0.01%
	-mercaptoethanol, 0.02% Bromophenol Blue) was added and boiled for 5 min
before separation in SDS-PAGE using 7.5% Ready Gel Tris-HCl gels (BioRad,
Hercules, CA). Electrotransfer of proteins from the gel to nitrocellulose
membrane was performed for 60 min at 100 V. The nitrocellulose transfers
were probed with anti–insulin receptor-	 subunit, anti–IGF-I receptor, and
anti–phospho AKT (Ser473) antibodies from Cell Signaling Technology as well
as 	-actin (Millipore) for the normalization. Subsequently, the blots were
incubated in SuperSignal West Pico Chemiluminescent substrates (Thermo
Scientiﬁc, Hanover Park, IL) for 5 min and visualized with autoradiography
ﬁlm (Denville Scientiﬁc, Metuchen, NJ). Quantiﬁcation was performed using
the National Institutes of Health Image J protocol.
Statistics. Factorial analyses of variance (ANOVA) or Student t tests were
used for between-subject comparisons involving 
2 or exactly 2 levels,
respectively. For analysis of in vivo studies on CBT one-way ANOVA with a
Tukey post hoc test (P  0.05) was used to determine differences in the mean
among multiple groups. Area under the curve (AUC) analysis was performed
using GraphPad Prism 4 Software. All results are expressed as means  SE.
Immunohistochemistry. Mice (n  4) were deeply anesthetized with
isoﬂorane (induction 3–5%; maintenance 1–1.5%) and placed in a Kopf
stereotactic frame (Kopf Instruments). A 33 G injector (SST-33/FT, Plastics
One, Roanoak, VA) was connected to a Hamilton syringe with a polyethylene
tubing and ﬁlled with Texas Red–conjugated Dextran beads (Invitrogen,
Carlsbad, CA; 1 mg/ml). The injector was inserted into the dorsomedial
hypothalamus (DMH) (AP  1.58 mm, Lat  0.25 mm; V  4.6 mm from the
surface of the brain; n  1) or raphe pallidus (RPa) (AP  6.12 mm, Lat 
0.0 mm; V  5.8 mm from the surface of the brain; n  3) according to
stereotactic coordinates (12), and 1 l of tracer was injected over 1 min.
Animals were allowed to recover for 7 days.
Animals were perfused via the ascending aorta with 10 ml of 0.9% NaCl
followed by 50 ml ice-cold 4% (wt/vol) paraformaldehyde in 0.16 mol/l PBS.
Brains were removed and postﬁxed for2hi nt h esame ﬁxative, then
transferred to PBS containing 20% (wt/vol) sucrose and stored overnight at
4°C. Sections from the POA were cut on a cryostat (Leica) at 40 m and
transferred to individual wells containing PBS.
For indirect immunohistochemistry free-ﬂoating sections were incubated
overnight with a rabbit anti–insulin receptor antibody (1:100; Pﬁzer PP5),
rinsed in PBS, and incubated with a Donkey anti-rabbit Alexa488 (1:200;
Invitrogen) for1hi nroom temperature. Sections were rinsed in PBS,
followed by incubation with 0.5 mol/l DAPI (Invitrogen) for 5 min, then
rinsed in PBS and mounted onto SuperFrost Plus sides (VWR, Ann Arbor, MI)
and mounted with ProLong Gold. Confocal images were captured using a
Zeiss laser confocal microscope using Zen 2009 Zeiss software suite (Carl
Zeiss, Thornwood, NY). All serial optical image sections (0.3-m interval step
slices) were imported and spatially reassembled using Imaris (Bitplane, Saint
Paul, MN) to generate a three-dimesional representation of the tissue and then
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Image Pro Plus (Media Cybernetics, Bethesda, MD).
RESULTS
Injection of insulin into the POA was followed by elevation
of CBT lasting up to6hi nadose-dependent manner (Fig.
1A). Similar to mice injected with a vehicle aCSF, animals
injected with insulin showed a stress-dependent elevation
of CBT at time of treatment. However, CBT returned to
baseline in vehicle-treated mice but not in animals that
received insulin. The extent of CBT elevation was dose
dependent: average CBT after injection (after stress-in-
duced peak, from 1–6 h after injection) was 35.77  0.04°C
for vehicle and 36.21  0.07, 36.98  0.03, 37.11  0.04, and
37.08  0.11°C (or 0.44, 1.21, 1.34, and 1.31°C,
respectively; P  0.01) for 0.001, 0.015, 0.03, and 0.06 IU of
insulin, respectively. The hyperthermic effects of insulin
were signiﬁcantly larger in the POA (1.34°C) than in the
DMH (0.78°C) (P  0.01) or the RPa (0.57°C; P  0.01),
which are projection areas for the POA warm-sensitive
neurons (Fig. 1B). Pretreatment of the animals with insu-
lin-neutralizing antibody (Fig. 1C) injected into the POA
prior to injection of insulin prevented the insulin-evoked
hyperthermic response. Insulin did not display hyperther-
mic effects when injected peripherally (intraperitoneally).
The average temperature from 1–6 h after intraperitoneal
injection was 36.28  0.07 and 36.22  0.10°C for vehicle
and insulin (0.03 IU), respectively (Fig. 1D).
Measurement of oxygen consumption, carbon dioxide
production, and the RER demonstrated that POA injection
of insulin was followed by increased oxygen consumption
and lower RER compared with vehicle-treated mice, indi-
cating a switch from glucose metabolism to elevated fatty
acid utilization (Fig. 2A). The lower RER upon POA insulin
injection compared with that of vehicle-treated mice was
prolonged and still present at 6 h postinjection. RER for
vehicle and 0.03 IU insulin POA was 0.91  0.02 and 0.75 
0.01, respectively, (P  0.01). Locomotor activity did not
contribute to CBT increase because it was not affected by
either vehicle or insulin injection in the POA (not shown).
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FIG. 1. Effects of central or peripheral insulin injections on CBT. A: Proﬁle of the dose-dependent effects of local injection of four different doses
of insulin (0.001, ; 0.015, E; 0.03, ; and 0.06 IU, ‚)( n  8 animals per group). B: Graph showing the differential effects on CBT of the injection
of 0.03 IU of insulin in the POA, the DMH, and the RPa (POA, E and F; DMH, ‚ and Œ; RPa,  and ; white  insulin and black  control). C:
Neutralizing antibody to insulin injected POA prior to insulin blocks the hyperthermic effects of insulin (insulin antibody, ‚ and Œ; vehicle, E and
F: white  insulin and black  vehicle). D: Graph showing the effects on CBT of intraperitoneal injection of 0.03 IU of insulin or vehicle. All graphs
show CBT proﬁle for the ﬁrst 6 h after injection. Arrow indicates time of injection; the CBT increase observed in all conditions during the ﬁrst
hour is due to stress associated with injection. Data are presented as means  SE.
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insulin injected into the POA activated BAT thermogenesis
because the insulin treatment induced up to ﬁvefold (P 
0.05) elevation in BAT glucose
18F-FDG uptake (Fig. 2B
and C). Because in the arcuate nucleus, insulin was shown
to activate the PI3K pathway (13), the hyperthermic effects
of insulin into the POA were also assessed in the presence
of a PI3K-I. Pretreatment with PI3K-I LY294002 (10 nmol in
0.5 l) before insulin (0.03 IU), both administered to the
POA 20 min apart, showed signiﬁcant attenuation of
insulin-induced hyperthermia (P  0.01) (Fig. 3A). Com-
parison of the area under the curve (AUC) for pretreat-
ment with PI3K-I followed by either insulin or vehicle did
not elicit statistically signiﬁcant results. The peak hyper-
thermic response to insulin administered to the POA was
observed 2 h after the pretreatment injection of vehicle. At
this time point pretreatment with PI3K-I reduced the
insulin-induced temperature elevation by 1.4°C (from 2.03
to 0.63°C) (Fig. 3A).
Biochemical analysis of POA tissues conﬁrmed the
presence of the insulin receptor in the POA. Comparative
analysis demonstrated that insulin (0.03 IU) treatment
induced an elevation of the activated phosphorylated form
of AKT(Ser 437): the level of pAKT increased 317  82.7%
compared with vehicle 90 min after the injection (Fig. 3B),
which is in line with the involvement of PI3K in the insulin
signaling in this hypothalamic area.
The hypothesis, suggested by the presence of the insulin
receptor transcript found by single-neuron chipping of
individual warm-sensitive neurons in the POA (in prepa-
ration), that insulin might act directly on warm-sensitive
neurons was also tested by electrophysiological recording
of the effects of insulin on primary warm-sensitive PO/
anterior hypothalamus (AH) neurons (WSN) in hypotha-
lamic slices. Insulin was locally applied to warm-sensitive
PO/AH neurons using a microperfusion tip. WSNs were
identiﬁed by measuring the change in the ﬁring rate during
a temperature ramp; the thermal coefﬁcient of the WSNs
was 0.93 impulses s
1 C
1 (Fig. 4A and B) as previously
described (14). Insulin (0.3 IU/ml) decreased the ﬁring rate
of the WSN from 1.1 to 0.3 Hz (i.e., by 73%) (Fig. 4C).
Similar experiments revealed that the ﬁring rates for 9 of
19 (43%) warm-sensitive PO/AH neurons tested were re-
versibly inhibited by insulin (0.3 IU/ml). The decrease in
ﬁring rate averaged 54  19% (n  9). The ﬁring rate
averaged 4.9  2.6 Hz (n  9) in control and 2.6  2.4 Hz
(n  9) in the presence of insulin. This effect was
accompanied by a hyperpolarization of 3.2  2.7 mV (n 
9). At 0.15 IU/ml insulin reduced the ﬁring rate of warm-
sensitive PO/AH neurons by 10  7% (n  3). These effects
are consistent with the current models of central thermal
regulation that state that the PO/AH sends an inhibitory
-aminobutyric acid (GABA)ergic signal to the thermoreg-
ulatory centers DMH and/or RPa and controls thermogen-
esis induced by local or skin cooling or by binding of
pyrogens to their receptors on warm-sensitive neurons
(10). Thus, inhibition of neuronal activity in the PO/AH
results in hyperthermia, whereas a decrease in activity
results in hypothermia (reviewed in [15]). As predicted by
this model, insulin-induced inhibition of the activity of
PO/AH warm-sensitive neurons resulted in hyperthermia.
We then tested whether insulin caused hyperpolariza-
tion and whether reduction in ﬁring rate involved the
activation of ATP-sensitive K
 channels (KATP channels)
as previously described on insulin effects in the arcuate
neurons (5). The KATP channel blocker glybenclamide (20
mol/l) was applied to the bath for 5 min prior to local
insulin application. The channel blocker increased the
ﬁring rate of all neurons tested by 21  15% (n  6) (Fig.
4D and E). The presence of glybenclamide blocked the
previously observed inhibitory effect of insulin (0.3 IU/ml)
on the ﬁring rate in warm-sensitive POA/AH neurons (Fig.
4D and E). The PI3K-I LY249002 (5 /min bath) inhibits the
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decreased RER, indicating an elevation of fatty acid utilization. B: The
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prevents the insulin-induced inhibition of the ﬁring rate of
the WSNs in the POA. The inhibitory effect of LY249002 on
insulin’s action (Fig. 4F and G) suggests that at least some
of the effects of insulin in the POA are exerted at the level
of regulating the ﬁring rate of WSNs and, through this
mechanism, the level of BAT activation and thermogene-
sis. No effects of leptin (0.1 mol/l) and hypoglycemia
(glucose 10–1 mmol/l) on the activity of WSN were
observed (data not shown), although in other hypotha-
lamic nuclei there are interactions among glucose, leptin,
and insulin signaling.
Retrograde tracing from the RPa (Fig. 5A) or DMH (not
shown) show labeled neurons in the POA. Immunohisto-
chemical detection of the insulin receptor shows colocal-
ization with retrogradely traced neurons projecting to the
RPa (Fig. 5A–E) as well as adjacent insulin receptor–
positive only neurons (Fig. 5E).
DISCUSSION
Injection of insulin into the preoptic area of the hypothal-
amus induced a speciﬁc and dose-dependent elevation of
CBT mediated by stimulation of BAT thermogenesis as
shown by imaging and RER measurement. These data
show how insulin, primarily known for its peripheral
action as a regulator of glucose uptake, may act as a
central stimulator of fatty acid oxidation in BAT. Retro-
grade tracing indicates that insulin receptor–expressing
warm-sensitive neurons activate BAT through projection
via the RPa. WSNs are functional components of the
neuronal circuitry that regulate temperature homeostasis.
These neurons are known to respond to local changes in
temperature and to pyrogens during infection or diseases.
Insulin applied on hypothalamic slices acted directly on
intrinsically warm-sensitive neurons by inducing hyperpo-
larization and reducing ﬁring rates. It should be noted that
the POA insulin doses used give rise to POA insulin
concentrations that are in the range of circulating plasma
concentrations of insulin and are unlikely to exert the BAT
effects via leakage to other brain areas or to the periphery.
However, not all WSN tested responded to insulin, and
none responded to leptin or changes in glucose concen-
trations (not shown), indicating that WSNs constitute a
heterogeneous population of neurons and that insulin
inhibits only a subset of these POA neurons; however, this
subset represents an input potent enough to the BAT
regulation to cause a hyperthermic response. The insulin-
sensitive WSNs may mediate actions important for the
energy balance and may participate in the thermic effects
of food, a phenomenon inversely correlated to the degree
of insulin resistance and of body fat and proposed to be
important in the development of obesity (16). Our data
show how insulin can affect BAT activity via central action
on warm-sensitive neurons. This is important in light of
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FIG. 3. The hyperthermic effects of POA injection of insulin are inhibited by the PI3K-I and induce an elevation of the activated phosphorylated
form of AKT. A: The 6-h proﬁle of the effects of PI3K-I treatment on insulin-induced elevation of CBT. Animals were pretreated with 10 nmoles
of PI3K-I in 0.5 l 20 min before injection of 0.03 IU of insulin; arrows indicate time of injections (PI3K-I,  and f; vehicle, E and F; white 
insulin and black  vehicle). B: Western blot analysis of POA tissues conﬁrmed the presence of the insulin receptor in the POA: the level of pAKT
increased 317  82.7% compared with vehicle 90 min after the injection of insulin to the POA. Data are presented as means  SE. *P < 0.05.
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diabetes.diabetesjournals.org DIABETES, VOL. 59, JANUARY 2010 47FIG. 4. Effects of temperature and insulin on the ﬁring-rate activity of a PO/AH warm-sensitive neuron and the role of KATP channels and
PI3K in the inhibitory effects of insulin on warm-sensitive PO/AH neurons. A: Spontaneous ﬁring activity of a PO/AH neuron at three
different temperatures. B: Firing rate versus temperature plot. The slope of the linear regression, indicated by the solid line, is 0.93
impulses s
1o C
1. C: Application of insulin (0.3 IU/ml) induced a small hyperpolarization (2mV) and decreased the ﬁring rate of the neuron
from 1.1 to 0.3 Hz. D: Bath application of the KATP channel blocker glybenclamide (20 mol/l) reduced the ﬁring rate of WSNs by 43%. In
the presence of the KATP blocker, insulin (0.3 IU/ml) did not affect the ﬁring rate of WSNs. E: Bar chart summarizing the effect of insulin
(0.3 IU/ml, n  9; 0.1 IU/ml; n  5), glybenclamide (20 mol/l; n  6), and insulin (0.3 IU/ml, n  6) in the presence of the blocker. F and
G: Bath application of the PI3K-I LY294002 (5 mol/l) prevents the insulin- (0.3 IU/ml; n  6) caused inhibition of ﬁring rate (F). Data are
presented as means  SE.
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in obesity (17,18). The demonstration that WSNs in the
POA respond directly to insulin with increased thermogen-
esis provides an important link between thermoregulation
and energy homeostasis.
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